New treatment option for Cholecystectomy, Laparoscopic
Official title ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly
ClinicalTrials.gov ID: NCT07001423
What this study is testing
- What it's testing
- The goal of this study is to compare safety and efficacy of laparoscopic cholecystectomy versus wait-and-see policy after endoscopic removal of common bile duct stones in elderly. The primary endpoint is a composite outcome: Death or major postoperative complications or recurrent biliary disease within 1 year after randomization.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 75 and older
You may be able to join if
- Common bile duct stones cleared after Endoscopic Retrograde Cholangio Pancreatography (ERCP)
- Age \>= 80 years or age 75-79 years with a Charlson Comorbidity index \>=2
- gallbladder in situ
You likely can't join if
- Acute Cholecystitis
- Biliary Pancreatitis
- Severe or moderately severe post-ERCP pancreatitis
- Chronic pancreatitis
- Bile duct pathology
- Widespread malignancy
See the full eligibility criteria
- Common bile duct stones cleared after Endoscopic Retrograde Cholangio Pancreatography (ERCP)
- Age \>= 80 years or age 75-79 years with a Charlson Comorbidity index \>=2
- gallbladder in situ
- Acute Cholecystitis
- Biliary Pancreatitis
- Severe or moderately severe post-ERCP pancreatitis
- Chronic pancreatitis
- Bile duct pathology
- Widespread malignancy
- Unable to give consent
The study team makes the final eligibility decision.
Where it's taking place
- Espoo, Finland
- Hämeenlinna, Finland
- Helsinki, Finland
- Joensuu, Finland
- Jyväskylä, Finland
- Kotka, Finland
- Kuopio, Finland
- Lahti, Finland
- Oulu, Finland
- Tampere, Finland
- Turku, Finland
- Vaasa, Finland
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 75 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Espoo, Finland; Hämeenlinna, Finland; Helsinki, Finland; Joensuu, Finland; Jyväskylä, Finland; Kotka, Finland and 6 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.